Krm Ayurveda IPO
SMEListedKrm Ayurveda IPO Details
Krm Ayurveda Financials ₹ in crore
Detailed financials for this issue aren’t available yet.
Krm Ayurveda IPO Strengths & Risks as disclosed in the DRHP
Strengths and risk factors from this issue’s prospectus aren’t available yet.
How to check Krm Ayurveda IPO allotment status
Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Krm Ayurveda Limited, the registrar is Skyline Financial Services Pvt. Ltd. — allotment is finalised in the days between the issue closing on TBA and listing on 29 Jan 2026.
The registrar publishes allotment on its own portal: Skyline. Your bank will also show the blocked amount released if shares were not allotted.
Krm Ayurveda IPO FAQs
What is the Krm Ayurveda IPO listing date?
The shares are scheduled to list on 29 January 2026 on NSE. Trading starts at 10:00 am IST after the special pre-open session that discovers the listing price.
Where can I read the Krm Ayurveda DRHP or RHP?
The offer document for the Krm Ayurveda Limited IPO is linked on this page as filed with the exchange; SEBI and the lead managers also host it.
What is a DRHP?
The Draft Red Herring Prospectus is the document a company files with SEBI before an IPO. It describes the business, the financials, the risk factors, the promoters and how the money raised will be used. The Red Herring Prospectus (RHP) is the version filed just before the issue opens, with the price band and dates added.
When was the Krm Ayurveda DRHP filed, and what is its status with SEBI?
Krm Ayurveda Limited filed its draft red herring prospectus on 22 September 2025; the exchange lists its status as "Approved". Issue dates and the price band are fixed later in the red herring prospectus, and this page is updated the day they are.
When will Krm Ayurveda IPO list?
The Krm Ayurveda Limited shares are scheduled to list on 29 January 2026 on NSE. The listing price is discovered in a special pre-open session from 9:00 am and normal trading begins at 10:00 am IST.
At what time does an IPO list?
On listing day the exchange runs a special pre-open session for the new stock from 9:00 am IST in which orders are collected and the listing price is discovered; continuous trading in the shares begins at 10:00 am IST.
Where does the Krm Ayurveda IPO data on this page come from, and how often is it updated?
Subscription figures are the exchange's own category-wise bids (NSE and BSE), refreshed every 5 minutes while bidding is open and frozen at the final tally after close. GMP is an unofficial grey-market indicator read about once an hour from third-party reporters, each reading timestamped. Price band, lot size, issue size, dates, registrar and lead managers are from the exchange's issue master and the offer document filed with SEBI. Financials and the shareholding pattern are as restated in the offer document; allotment is published only by the registrar, which this page links to. Anchor investor allocations, where shown, are the exchange's anchor allocation file.
Krm Ayurveda IPO Registrar where allotment and refund queries go
The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.
What is GMP in an IPO?
Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹40 on a upper band means the grey market is dealing at issue price plus that premium.
The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.